News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Lonza Group Ltd. to Invest $150 Million in Genome Valley
May 22, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
PharmaBiz -- Switzerland-based Lonza, one of the global biopharmaceutical giants, would make an investment of US $150 million (around Rs 750 crore) for two major projects in Genome Valley, which is located at the outskirts of Hyderabad.
Twitter
LinkedIn
Facebook
Email
Print
Asia
Lonza
MORE ON THIS TOPIC
Weight loss
GSK goes beyond weight-loss with $1B buyout of Chinese siRNA specialist
May 7, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
Lilly investing billions to prepare for overseas oral GLP-1 launches
April 14, 2026
·
2 min read
·
Nick Paul Taylor
Manufacturing
USP adds Tamiflu, Trulicity to vulnerable list as upstream analysis reshapes supply concerns
April 13, 2026
·
2 min read
·
Nick Paul Taylor
Pain
AbbVie enters world of pain in up to $715M deal with China’s Haisco
April 13, 2026
·
1 min read
·
Annalee Armstrong
